newsroom
Defense Tech · Defense programs (Janus, Pele) de-risk nuclear/robotics supply chains; GPS/internet/rocketry playbook repeats
now playing · Defense Tech
Fusion reaches commercial inflection: Helion Microsoft PPA, modular gigafactory approach, 2028 target
Helion's direct electricity extraction (95% efficiency) enables mass-producible 50MW modules. Microsoft PPA de-risks demand. Advance Act regulatory pathway (state-level, ~1 year) vs NRC dec…
Entries achieves first US non-light-water criticality in 40 years; military Janus program $2B anchor demand
Liquid metal heat pipes enable passive cooling at atmospheric pressure, deployable in water-scarce environments. DOE/Army regulatory pathway operational (Project Pele → Advance Act). TRISO…
PwC sees $16T AI GDP by 2030 but gains highly concentrated in US; Europe regulating not investing
AI is first productivity supercycle since globalization/women entering workforce. US capturing disproportionate value (hyperscalers, labs, chips). Europe's risk-mitigation culture (regulati…
AI Drug Discoverytailwindscore 8/10samuel hom
AI compressing 10-year drug development: systematic reviews 2yr→4hr, KRAS molecular glue, combo therapies
Sematic Labs automates systematic reviews (regulatory bottleneck). Revolution Medicines drugs 'undruggable' KRAS with molecular glue, doubling pancreatic cancer survival. Tango combos exten…
Scaling laws proven in robotics: Generalist Gen 1 crosses commercial viability for dexterous manipulation
First demonstration of predictable performance scaling with compute/data in robotics (Gen 0 Nov 2024). Gen 1 (Apr 2025) achieves reliability/speed for industrial tasks (wire harnessing, uns…
Defense Techtailwindscore 8/10jordan bramble
Defense programs (Janus, Pele) de-risk nuclear/robotics supply chains; GPS/internet/rocketry playbook repeats
Military provides: 1) committed demand (Janus $2B for microreactors), 2) regulatory pathway (Army/DOE licensing), 3) supply chain investment (TRISO fuel line), 4) operational proof points (…
Pharma patent cliffs prevent $100T valuations; manufacturing scale for $50B drugs creates capex moat
Unlike software, biologics face 95% revenue erosion post-patent. Tirzepatide ($51B) and semaglutide will face generic competition. Manufacturing at $50B scale requires specialized facilitie…
Space Economytailwindscore 7/10john coogan
Starlink profitability via Google compute deal enables S&P inclusion; retail demand may exceed float
Google ~$1B/month Starlink compute purchase + Anthropic deal drives GAAP profitability. S&P inclusion requires GAAP profit — achievable within year. $60B+ valuation implies large float; ret…
Lived experience S-tier, internet video B-tier, simulation C-tier: data quality > quantity for physical AI
Generalist's tier list reveals physical world data hierarchy: human teleoperation with full sensory feedback (S) > YouTube video (B) > mocap (C) > simulation (C) > internet text (B) > synth…